Hoya Corporation Pentax Medical sells C2 CryoBalloon product line to Merit Medical Systems through asset purchase agreement

Reuters
10/16
Hoya Corporation Pentax Medical sells C2 CryoBalloon product line to <a href="https://laohu8.com/S/MMSI">Merit Medical Systems</a> through asset purchase agreement

PENTAX Medical, a division of HOYA Group, has announced an asset purchase agreement to sell its C2 CryoBalloon™ product line to Merit Medical Systems. The transaction will allow PENTAX Medical to focus on its core business of flexible reusable endoscopy, while Merit Medical will integrate the C2 CryoBalloon™ technology into its endoscopy portfolio. Manufacturing will be transferred to Merit's facility in Utah, and several PENTAX Medical employees will join Merit Medical as part of the transition.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hoya Corporation published the original content used to generate this news brief via CNW (Ref. ID: C6614) on October 15, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10